Literature DB >> 26643686

Drug Side Effect Symptoms and Adherence to Antihypertensive Medication.

Yacob G Tedla1, Leonelo E Bautista2.   

Abstract

BACKGROUND: Non-adherence to antihypertensive medication increases the risk of uncontrolled hypertension. Antihypertensive drug-related symptoms (side effects) are frequently cited as a main cause of non-adherence, but with little support from prospective studies. We evaluated the association between drug side effects and prospective adherence to treatment.
METHODS: We collected data on the number and dose of antihypertensive drugs at enrollment and at 3, 6, 9, and 12 months of follow-up in a cohort of 175 hypertensive patients starting or restarting antihypertensive treatment (mean age: 50 years; 58% women). During the follow-up visits, we gathered data on 24 side effects during the last month and the pill count adherence ratio (PCAR = pills taken out of number prescribed × 100) since the previous visit. The association between side effects at a visit and adherence through the next visit was estimated using mixed effect models.
RESULTS: Eighty-five percent of the participants experienced side effects, and 34.5% became non-adherent (PCAR <80%). After adjusting for confounders, PCAR was 6.0 percentage points lower (P = 0.04) among individuals with number of side effects above the median value (4 symptoms). Also, in individuals with genitourinary side effects, PCAR was 7.1 percentage points lower (P = 0.02) than in those without such side effects. Specifically, PCAR was 6.5 (P = 0.06) and 7.6 (P = 0.01) percentage points lower among individuals with excessive urination and decrease in sexual drive, respectively.
CONCLUSION: Antihypertensive drug side effects was associated with drug adherence but only excessive urination and decrease in sexual drive significantly predicted lower adherence. These symptoms could be used as markers to screen out patients at high risk of non-adherence. © American Journal of Hypertension, Ltd 2015. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  blood pressure; cohort study; drug side effects; hypertension; medication adherence.

Mesh:

Substances:

Year:  2015        PMID: 26643686      PMCID: PMC5863783          DOI: 10.1093/ajh/hpv185

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  31 in total

1.  Determinants of discontinuation of new courses of antihypertensive medications.

Authors:  Jean-Pierre Grégoire; Jocelyne Moisan; Rémi Guibert; Antonio Ciampi; Alain Milot; Michel Gaudet; Isabelle Côté
Journal:  J Clin Epidemiol       Date:  2002-07       Impact factor: 6.437

2.  Uncontrolled hypertension and increased risk for incident heart failure in older adults with hypertension: findings from a propensity-matched prospective population study.

Authors:  Anand S Iyer; Mustafa I Ahmed; Gerasimos S Filippatos; O James Ekundayo; Inmaculada B Aban; Thomas E Love; Navin C Nanda; George L Bakris; Gregg C Fonarow; Wilbert S Aronow; Ali Ahmed
Journal:  J Am Soc Hypertens       Date:  2010 Jan-Feb

3.  Does low participation in cohort studies induce bias?

Authors:  Ellen Aagaard Nohr; Morten Frydenberg; Tine Brink Henriksen; Jorn Olsen
Journal:  Epidemiology       Date:  2006-07       Impact factor: 4.822

4.  [Bias from dependent errors in observational studies].

Authors:  Petter Kristensen
Journal:  Tidsskr Nor Laegeforen       Date:  2005-01-20

5.  DAGitty: a graphical tool for analyzing causal diagrams.

Authors:  Johannes Textor; Juliane Hardt; Sven Knüppel
Journal:  Epidemiology       Date:  2011-09       Impact factor: 4.822

6.  Antihypertensive medication-taking. Investigation of a simple regimen.

Authors:  D Guerrero; P Rudd; C Bryant-Kosling; B Middleton; B ] Middleton BF [corrected to Middleton
Journal:  Am J Hypertens       Date:  1993-07       Impact factor: 2.689

7.  Impact of medication adherence on hospitalization risk and healthcare cost.

Authors:  Michael C Sokol; Kimberly A McGuigan; Robert R Verbrugge; Robert S Epstein
Journal:  Med Care       Date:  2005-06       Impact factor: 2.983

8.  Can simple clinical measurements detect patient noncompliance?

Authors:  R B Haynes; D W Taylor; D L Sackett; E S Gibson; C D Bernholz; J Mukherjee
Journal:  Hypertension       Date:  1980 Nov-Dec       Impact factor: 10.190

9.  Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients.

Authors:  Giampiero Mazzaglia; Ettore Ambrosioni; Marianna Alacqua; Alessandro Filippi; Emiliano Sessa; Vincenzo Immordino; Claudio Borghi; Ovidio Brignoli; Achille P Caputi; Claudio Cricelli; Lorenzo G Mantovani
Journal:  Circulation       Date:  2009-10-05       Impact factor: 29.690

10.  Measuring adherence in a hypertension clinical trial.

Authors:  Glenys A Hamilton
Journal:  Eur J Cardiovasc Nurs       Date:  2003-09       Impact factor: 3.908

View more
  29 in total

1.  TRPV1 (Transient Receptor Potential Vanilloid 1) Cardiac Spinal Afferents Contribute to Hypertension in Spontaneous Hypertensive Rat.

Authors:  Julia Shanks; Sharon D B de Morais; Lie Gao; Irving H Zucker; Han-Jun Wang
Journal:  Hypertension       Date:  2019-08-19       Impact factor: 10.190

2.  Response to "Antihypertensive Drug-Related Side Effects: Is it the Unique Indicator for Nonadherence?".

Authors:  Yacob G Tedla; Leonelo E Bautista
Journal:  Am J Hypertens       Date:  2016-03-17       Impact factor: 2.689

3.  Factors associated with false-positive self-reported adherence to antihypertensive drugs.

Authors:  Y G Tedla; L E Bautista
Journal:  J Hum Hypertens       Date:  2016-11-17       Impact factor: 3.012

Review 4.  A practical approach to the pharmacological management of hypertension in older people.

Authors:  Nikesh Parekh; Amy Page; Khalid Ali; Kevin Davies; Chakravarthi Rajkumar
Journal:  Ther Adv Drug Saf       Date:  2016-12-27

Review 5.  Obstructive Sleep Apnea and Arterial Hypertension: Implications of Treatment Adherence.

Authors:  Tomás Posadas; Francisco Campos-Rodriguez; Esther Sapiña-Beltrán; Grace Oscullo; Gerard Torres; Miguel Angel Martinez-Garcia
Journal:  Curr Hypertens Rep       Date:  2020-02-03       Impact factor: 5.369

Review 6.  Nonbiologic factors that impact management in women with urinary incontinence: review of the literature and findings from a National Institute of Diabetes and Digestive and Kidney Diseases workshop.

Authors:  Jenna M Norton; Jennifer L Dodson; Diane K Newman; Rebecca G Rogers; Andrea D Fairman; Helen L Coons; Robert A Star; Tamara G Bavendam
Journal:  Int Urogynecol J       Date:  2017-07-03       Impact factor: 2.894

7.  Glecaprevir-pibrentasvir for chronic hepatitis C: Comparing treatment effect in patients with and without end-stage renal disease in a real-world setting.

Authors:  Hsu-Heng Yen; Pei-Yuan Su; Ya-Huei Zeng; I-Ling Liu; Siou-Ping Huang; Yu-Chun Hsu; Yang-Yuan Chen; Chia-Wei Yang; Shun-Sheng Wu; Kun-Ching Chou
Journal:  PLoS One       Date:  2020-08-13       Impact factor: 3.240

8.  Combined management can decrease blood pressure: an investigation of health-seeking behaviors among hypertensive patients in urban communities in China.

Authors:  Si Wang; Kai Liu; Xin Zhang; Qingtao Meng; Xinran Li; Runyu Ye; Zhipeng Zhang; Xiaoping Chen
Journal:  BMC Cardiovasc Disord       Date:  2021-05-25       Impact factor: 2.298

9.  Predictors of medication nonadherence among hypertensive clients in a Ghanaian population: Application of the Hill-Bone and Perceived Barriers to Treatment Compliance Scale.

Authors:  Eric Woode; Eric Boakye-Gyasi; Yaa Obirikorang; Evans A Adu; Christian Obirikorang; Emmanuel Acheampong; Enoch Odame-Anto
Journal:  Health Sci Rep       Date:  2022-04-13

10.  The Ecology of Antihypertensives in the United States, 1997-2017.

Authors:  Michael E Johansen; Joshua D Niforatos; Jeremey B Sussman
Journal:  J Gen Intern Med       Date:  2020-09-23       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.